Literature DB >> 6181035

Description of monoclonal antibody defining an HLA allotypic determinant that includes specificities within the B5 cross-reacting group.

B F Haynes, E G Reisner, M E Hemler, J L Strominger, G S Eisenbarth.   

Abstract

The selection and characterization of a cloned murine monoclonal antibody (4D12) that defines an HLA allotypic determinant is described. Antibody 4D12 immunoprecipitates HLA heavy and light chains. From studies on 4D12 reactivity with a large panel of well-characterized target cells, antibody 4D12 defines a public HLA determinant that includes specificities within but not identical to the B5 cross-reacting group. Antibody 4D12 should be useful in the study of HLA-B5--related supratypic antigens.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6181035     DOI： 10.1016/0198-8859(82)90001-5

Source DB:  PubMed          Journal:  Hum Immunol        ISSN： 0198-8859            Impact factor:   2.850


  14 in total

1.  Human thymocytes bind to autologous and allogeneic thymic epithelial cells in vitro.

Authors:  K H Singer; L S Wolf; D F Lobach; S M Denning; D T Tuck; A L Robertson; B F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

2.  MHC-E-Restricted CD8+ T Cells Target Hepatitis B Virus-Infected Human Hepatocytes.

Authors:  Benjamin J Burwitz; Patrick K Hashiguchi; Mandana Mansouri; Christine Meyer; Roxanne M Gilbride; Sreya Biswas; Jennie L Womack; Jason S Reed; Helen L Wu; Michael K Axthelm; Scott G Hansen; Louis J Picker; Klaus Früh; Jonah B Sacha
Journal:  J Immunol       Date:  2020-03-11       Impact factor: 5.422

3.  Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells.

Authors:  Y Shimizu; B Koller; D Geraghty; H Orr; S Shaw; P Kavathas; R DeMars
Journal:  Mol Cell Biol       Date:  1986-04       Impact factor: 4.272

4.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

Authors:  R D Salter; D N Howell; P Cresswell
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens.

Authors:  R DeMars; R Rudersdorf; C Chang; J Petersen; J Strandtmann; N Korn; B Sidwell; H T Orr
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

6.  A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypes.

Authors:  F M Brodsky
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

7.  DNA methylation and expression of HLA-DR alpha.

Authors:  M S Reitz; D L Mann; M Eiden; C D Trainor; M F Clarke
Journal:  Mol Cell Biol       Date:  1984-05       Impact factor: 4.272

8.  Yersinia enterocolitica serotype O:3 alters the expression of serologic HLA-B27 epitopes on human monocytes.

Authors:  M Wuorela; S Jalkanen; J Kirveskari; P Laitio; K Granfors
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

9.  Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.

Authors:  M B Sztein; P S Steeg; H M Johnson; J J Oppenheim
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

10.  Two subtypes of HLA-B51 differing by substitution at position 171 of the alpha 2 helix.

Authors:  G Kawaguchi; W H Hildebrand; M Hiraiwa; S Karaki; T Nagao; N Akiyama; H Uchida; K Kashiwase; T Akaza; R C Williams
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.